ProPhase Labs, Inc. (PRPH) Financial Statements (2024 and earlier)

Company Profile

Business Address 711 STEWART AVE, SUITE 200
NEW YORK, NY 11530
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments17,43717,2638,4551,3608,24121,938
Cash and cash equivalents9,1098,4086,8164341,5543,173
Short-term investments8,3288,8551,6399266,68718,765
Receivables37,05437,7083,1552,0102,9682,447
Inventory, net of allowances, customer advances and progress billings3,9764,6003,0391,4591,9031,531
Inventory3,9764,6003,0391,4591,9031,531
Prepaid expense      143
Asset, held-for-sale, not part of disposal group      22
Other undisclosed current assets2,3661,7461,2385,1165,1262,838
Total current assets:60,83361,31715,8879,94518,23828,919
Noncurrent Assets
Operating lease, right-of-use asset4,0594,4024,731 
Property, plant and equipment7,2885,9473,5782,3292,4992,742
Intangible assets, net (including goodwill)14,18416,5612,135   
Goodwill5,7095,709901   
Intangible assets, net (excluding goodwill)8,47510,8521,234   
Prepaid expense1214602,084   
Deferred income tax assets    
Other noncurrent assets1,163608240   
Other undisclosed noncurrent assets   2,750  2,500
Total noncurrent assets:26,81527,97815,5182,3292,4995,242
TOTAL ASSETS:87,64889,29531,40512,27420,73734,161
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,9057,0263,7714323,366762
Interest and dividends payable   2,929 
Accounts payable5,9057,0263,771432437562
Accrued liabilities     200
Deferred revenue2,4992,034  
Debt      
Other liabilities2,0723,8071,731409766310
Other undisclosed current liabilities5,5992,65779292101 
Total current liabilities:16,07515,5246,2949334,2331,072
Noncurrent Liabilities
Long-term debt and lease obligation2,40014,23814,393   
Long-term debt, excluding current maturities 2,40010,0409,991   
Finance lease, liability    
Liabilities, other than long-term debt5,542905162110  
Deferred revenue1,059905162110
Deferred income tax liabilities 224   
Operating lease, liability4,2594,1984,402 
Other undisclosed noncurrent liabilities      
Total noncurrent liabilities:7,94215,14314,555110  
Total liabilities:24,01730,66720,8491,0434,2331,072
Equity
Equity, attributable to parent63,63158,62810,55611,23116,50433,089
Common stock161614141414
Treasury stock, value(58,033)(48,407)(47,490)(47,490)(47,490)(47,025)
Additional paid in capital109,138104,55261,67460,21559,47158,034
Accumulated other comprehensive income (loss)757(175)(11)(2)(24)(78)
Retained earnings (accumulated deficit)11,7532,642(3,631)(1,506)4,53322,144
Total equity:63,63158,62810,55611,23116,50433,089
TOTAL LIABILITIES AND EQUITY:87,64889,29531,40512,27420,73734,161

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues122,64779,04214,5149,87613,1269,867
Revenue, net9,867
Cost of revenue
(Cost of Goods and Services Sold)
(51,993)(37,054)(9,908)(7,261)(8,345)(7,919)
Other undisclosed gross profit      
Gross profit:70,65441,9884,6062,6154,7811,948
Operating expenses(47,059)(32,187)(8,591)(5,854)(6,415)(5,938)
Other undisclosed operating income   1,892   
Operating income (loss):23,5959,801(2,093)(3,239)(1,634)(3,990)
Nonoperating income (expense)7764262133  
Investment income, nonoperating 7764262133  
Other nonoperating expense      
Interest and debt expense(764)(1,148)(295)  (54)
Other undisclosed income from continuing operations before equity method investments, income taxes      
Income (loss) from continuing operations before equity method investments, income taxes:22,9089,295(2,326)(3,106)(1,634)(4,044)
Other undisclosed income (loss) from continuing operations before income taxes (3,990)  167381
Income (loss) from continuing operations before income taxes:22,9085,305(2,326)(3,106)(1,467)(3,663)
Income tax expense (benefit)(4,445)968  (103)17,990
Income (loss) from continuing operations:18,4636,273(2,326)(3,106)(1,570)14,327
Income (loss) before gain (loss) on sale of properties:6,273(2,125)(3,146)(1,740)41,831
Income (loss) from discontinued operations   201(40)(170)27,504
Net income (loss) attributable to parent:18,4636,273(2,125)(3,146)(1,740)41,831
Other undisclosed net income available to common stockholders, basic1     
Net income (loss) available to common stockholders, basic:18,4646,273(2,125)(3,146)(1,740)41,831
Other undisclosed net income available to common stockholders, diluted6321,000    
Net income (loss) available to common stockholders, diluted:19,0967,273(2,125)(3,146)(1,740)41,831

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):18,4636,273(2,125)(3,146)(1,740)41,831
Comprehensive income (loss):18,4636,273(2,125)(3,146)(1,740)41,831
Other undisclosed comprehensive income (loss), net of tax, attributable to parent932(164)(9)2254(78)
Comprehensive income (loss), net of tax, attributable to parent:19,3956,109(2,134)(3,124)(1,686)41,753

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: